Project Grant 2542232
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $464,750 to Icahn School of Medicine at Mount Sinai on July 7, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project completion period extending through June 30, 2027. The award supports research focused on understanding and modulating T cell plasticity, specifically the transdifferentiation of TH17 cells into regulatory T cells...
- Federal Grant Award Summary The National Science Foundation's Division of Molecular and Cellular Biosciences awarded $763,328 to the Research Foundation of the City University of New York (RFCUNY), operating as the Advanced Science Research Center, on June 15, 2026, under the Biological Sciences program (CFDA 47.074). This CAREER project grant, extending through May 31, 2031, supports fundamental research in protein design with the objective of developing improved designed proteins that...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $745,195 under the Military Medical Research and Development program (CFDA 12.420) to accelerate personalized T-cell receptor (TCR) immunotherapy for microsatellite-stable colorectal cancer through development of a multimodal prediction model. The three-year award, effective September 1, 2026 through August 31, 2029, supports research and development...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Icahn School of Medicine at Mount Sinai a Project Grant of $462,981.00 under the Biomedical Research and Research Training program (CFDA 93.859) on August 15, 2025, with a completion date of July 31, 2030. This research initiative addresses sepsis, a leading cause of hospital mortality worldwide, by leveraging modern biobanks to advance understanding of sepsis biology and clinical outcomes. The...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $929,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 23, 2025, with completion targeted for June 30, 2027. The grant supports research investigating the mechanisms of action of messenger ribonucleic acid (mRNA)-based and Newcastle Disease Virus (NDV)-based vaccine platforms in...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $101,396.00 to Icahn School of Medicine at Mount Sinai under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective March 10, 2026, with completion anticipated by September 14, 2029. The award supports investigator-initiated biomedical research examining how hepatocytes and skeletal myocytes influence adaptive immune responses to messenger RNA (mRNA)...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Icahn School of Medicine at Mount Sinai a $462,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of February 4, 2026, through January 31, 2028. This research initiative focuses on developing FAB-fragment drug conjugates (FDCs) as an innovative therapeutic platform to improve organ transplant outcomes. The project aims to design...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $591,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2027. The award supports research titled "Decoding the Tumor Microenvironment Remodeling of Cancer Vaccine Treatment in Pleural Mesothelioma," to be conducted at the institution's New York, NY location. This project...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $507,000 Project Grant to Icahn School of Medicine at Mount Sinai on August 7, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year research initiative extending through July 31, 2030. The research project, titled "Engineering Metal Ion-Immunity Crosstalk for Metalloimmunotherapy," focuses on understanding how metal ions interact...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $695,546 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025 through September 30, 2027. The award supports research on central nervous system (CNS)-targeted antisense therapeutics for Powassan virus infection, conducted at the institution's New York, NY facility. This project aligns with the DHA's mission to develop...
Award Details: Icahn School of Medicine at Mount Sinai received a $204,412.00 CAREER Project Grant from the National Science Foundation's Division of Information and Intelligent Systems under the Computer and Information Science and Engineering (CISE) program (CFDA 47.070). The award, initiated July 1, 2026, extends through June 30, 2031, and supports research in computational immunology and protein language modeling at the institution's New York location. Deliverables and Services: This project will develop structure-aware protein language models to decode T cell receptor recognition mechanisms and their interaction with peptide antigens presented by major histocompatibility complex molecules. The research will produce computational methods integrating sequence, structure, and spatial information using transformer architecture with masked multimodal prediction and contrastive learning approaches. Key deliverables include high-confidence three-dimensional models of paired T cell receptors, novel computational frameworks linking receptor recognition with cellular function through integration with single-cell transcriptomic profiles, and openly shared software, datasets, and educational materials. The award also supports a month-long summer program in New York City introducing high school students to immunology, data science, and machine learning through hands-on projects and mentorship, with experimental validation studies conducted to refine the research framework iteratively. These outputs are intended to advance understanding of immune recognition with applications to cancer immunotherapy, autoimmunity, and future biomedical discovery.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $204.4k | 5/25/26 |